APA (7th ed.) Citation

Stauffer, V. L., Dodick, D. W., Zhang, Q., Carter, J. N., Ailani, J., & Conley, R. R. (2018). Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial. JAMA neurology, 75(9), 1080. https://doi.org/10.1001/jamaneurol.2018.1212

Chicago Style (17th ed.) Citation

Stauffer, Virginia L., David W. Dodick, Qi Zhang, Jeffrey N. Carter, Jessica Ailani, and Robert R. Conley. "Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial." JAMA Neurology 75, no. 9 (2018): 1080. https://doi.org/10.1001/jamaneurol.2018.1212.

MLA (9th ed.) Citation

Stauffer, Virginia L., et al. "Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial." JAMA Neurology, vol. 75, no. 9, 2018, p. 1080, https://doi.org/10.1001/jamaneurol.2018.1212.